Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
The date has been set for oral arguments to begin over who owns the patent rights to the gene-editing wonder CRISPR-Cas9. Berkeley's Jennifer Doudna and her.. 
No comment yet.
Sign up to comment
|
Scoop.it!
BigField GEG Tech's insight:
An Australian grandmother, Yvonne D'arcy, has won her fight - a breast cancer gene will not be patented.
|
Berkeley’s Jennifer Doudna and her colleague from the Max Planck Institute Emmanuelle Charpentier head to court on December 6th to face off against MIT’s Feng Zhang and present their argument before three US Patent and Trademark Office judges on why they, not Zhang, deserve the to own the patent that potentially holds the key to eradicating all inherited diseases.